2031년까지 글로벌 및 포르투갈 암 치료제 시장 전망

Global & Portugal Cancer Therapeutics Market to 2031

상품코드Poland Cancer Therapeutics Market.pdf
발행기관Business Market Insights
발행일2025.05.26
페이지 수100 Pages
포맷PDF
커버리지Country

₩3,600,000 – ₩6,600,000

보고서 요약(국문)

GLOBOCAN 2022 데이터에 따르면, 포르투갈에서는 그해 69,567건의 새로운 암 환자가 발생했으며, 유방암과 전립선암이 가장 흔하게 진단되었습니다. 암으로 인한 사망자는 약 33,762명에 달했습니다. 이러한 암 발병률 증가는 더욱 발전되고 효과적인 치료법에 대한 수요를 촉진하고 있습니다. 환자 수가 지속적으로 증가함에 따라 암 치료제 시장도 확대되고 있으며, 의료 서비스 제공자들은 생명을 구하는 치료법에 대한 접근성을 개선하고 환자 예후를 향상시키기 위해 노력하고 있습니다. 암 발병률과 관련 사망률의 증가는 제약 회사들이 혁신적인 치료법을 개발하기 위한 연구 개발에 투자하도록 유도하고 있습니다.

포르투갈 정부는 다양한 보건 정책과 국가 전략을 통해 암 치료 환경을 강화하기 위한 적극적인 조치를 취하고 있습니다. 2023년 2월, 포르투갈은 미국과 암 연구, 교육, 예방, 진단 및 치료 분야에서 협력을 증진하기 위한 협정을 체결했습니다. 또한, 정부는 최첨단 치료법에 대한 접근성을 개선하는 정책을 도입하여 환자들이 시의적절하고 효과적인 암 치료를 받을 수 있도록 보장하고 있습니다.

보고서 요약(영어 원문)

According to GLOBOCAN 2022 data, Portugal reported 69,567 new cancer cases that year, with breast and prostate cancers being the most frequently diagnosed. Approximately 33,762 deaths were attributed to cancer. This rising cancer incidence is driving the demand for more advanced and effective treatment options. As the number of patients continues to grow, the cancer therapeutics market is expanding, with healthcare providers striving to improve access to life-saving therapies and enhance patient outcomes. The increasing rates of cancer cases and related mortality are also prompting pharmaceutical companies to invest in research and development to deliver innovative therapies.

The Portuguese government has taken active steps to strengthen its cancer care landscape through various health initiatives and national strategies. In February 2023, Portugal signed a cooperative agreement with the United States aimed at fostering collaboration in cancer research, education, prevention, diagnostics, and treatment. In addition, the government has introduced policies to improve access to cutting-edge therapies, ensuring that patients receive timely and effective cancer care.

상세 목차

TABLE OF CONTENTS

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation:

4. Portugal Cancer Therapeutics Market Landscape

4.1 Overview

4.2 Ecosystem Analysis

4.2.1 List of Vendors in the Value Chain

5. Cancer Therapeutics Market Key Market Dynamics

5.1 Cancer Therapeutics Market – Key Market Dynamics

5.2 Market Drivers

5.3 Market Restraints

5.4 Market Opportunities

5.5 Future Trends

5.6 Impact of Drivers and Restraints

6. Portugal Cancer Therapeutics Market – Analysis

6.1 Portugal Cancer Therapeutics Market Revenue (US$ Million), 2021–2031

6.2 Portugal Cancer Therapeutics Market Revenue and Forecast Analysis

7. Portugal Cancer Therapeutics Market Analysis – by Therapy Types

7.1 Portugal Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types

8. Portugal Cancer Therapeutics Market Analysis – by Indications

8.1 Portugal Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

9. Portugal Cancer Therapeutics Market Analysis – by Distribution Channel

9.1 Portugal Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis by Key Players

10.1 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.2 Partnerships and Collaborations

11.2 Other Developments

12. Company Profiles

12.1 Bristol-Myers Squibb Co

12.1. 1 Key Facts

12.1. 2 Business Description

12.1. 3 Products and Services

12.1. 4 Financial Overview

12.1. 5 SWOT Analysis

12.1. 6 Key Developments

12.2 AbbVie Inc

12.2. 1 Key Facts

12.2. 2 Business Description

12.2. 3 Products and Services

12.2. 4 Financial Overview

12.2. 5 SWOT Analysis

12.2. 6 Key Developments

12.3 Johnson & Johnson

12.3. 1 Key Facts

12.3. 2 Business Description

12.3. 3 Products and Services

12.3. 4 Financial Overview

12.3. 5 SWOT Analysis

12.3. 6 Key Developments

12.4 F. Hoffmann-La Roche Ltd

12.4. 1 Key Facts

12.4. 2 Business Description

12.4. 3 Products and Services

12.4. 4 Financial Overview

12.4. 5 SWOT Analysis

12.4. 6 Key Developments

12.5 Pfizer Inc

12.5. 1 Key Facts

12.5. 2 Business Description

12.5. 3 Products and Services

12.5. 4 Financial Overview

12.5. 5 SWOT Analysis

12.5. 6 Key Developments

12.6 AstraZeneca Plc

12.6. 1 Key Facts

12.6. 2 Business Description

12.6. 3 Products and Services

12.6. 4 Financial Overview

12.6. 5 SWOT Analysis

12.6. 6 Key Developments

12.7 Merck KGaA

12.7. 1 Key Facts

12.7. 2 Business Description

12.7. 3 Products and Services

12.7. 4 Financial Overview

12.7. 5 SWOT Analysis

12.7. 6 Key Developments

12.8 Novartis AG

12.8. 1 Key Facts

12.8. 2 Business Description

12.8. 3 Products and Services

12.8. 4 Financial Overview

12.8. 5 SWOT Analysis

12.8. 6 Key Developments

12.9 Astellas Pharma Inc

12.9. 1 Key Facts

12.9. 2 Business Description

12.9. 3 Products and Services

12.9. 4 Financial Overview

12.9. 5 SWOT Analysis

12.9. 6 Key Developments

12.10 Eli Lilly and Co

12.10. 1 Key Facts

12.10. 2 Business Description

12.10. 3 Products and Services

12.10. 4 Financial Overview

12.10. 5 SWOT Analysis

12.10. 6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

언급된 주요 기업들

TABLE OF COMPANIES

1. Bristol-Myers Squibb Co

2. AbbVie Inc

3. Johnson & Johnson

4. F. Hoffmann-La Roche Ltd

5. Pfizer Inc

6. AstraZeneca Plc

7. Merck KGaA

8. Novartis AG

9. Astellas Pharma Inc

10. Eli Lilly and Co

표 목록 (Tables)

TABLE OF TABLES

Table 1. Portugal Cancer Therapeutics Market Segmentation

Table 2. List of Vendors

Table 3. Portugal Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)

Table 4. Portugal Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 5. Portugal Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types

Table 6. Portugal Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types

Table 7. Portugal Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 8. Portugal Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 9. Portugal Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 10. Portugal Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 11. List of Abbreviations

그림 목록 (Figures)

TABLE OF FIGURES

Figure 1. Impact Analysis of Drivers and Restraints

Figure 2. Portugal Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031

Figure 3. Heat Map Analysis by Key Players

Figure 4. Company Positioning and Concentration